BEIJING, June 23, 2022 /PRNewswire/ On June 23, Berry Oncology, a global leading company specialized in genomic testing and early cancer screening, announced the launch of its innovative one-time precision product HIFI Pan-Cancer Screening, which is an early multi-cancer screening product developed based on the company's proprietary HIFI technology platform. With one single testing, the product can accurately detect 6 high-risk and high-incident cancers in China that include lung cancer, esophageal cancer, gastric cancer, liver cancer, pancreatic cancer, and colorectal cancer, with a global leading performance of 87.58% sensitivity, 99.09% specificity and 82% traceability accuracy. Cancer has become a global public health challenge. According to the 2020 global cancer burden data released by the International Agency for Research on Cancer (IARC), there were 19.29 million new cancer cases and 9.96 million cancer deaths worldwide in 2020, while the numbers in China were 4.57 million
/PRNewswire/ Qiming Venture Partners portfolio company Arrail Group (SEHK: 06639), a leading dental services provider in China, today listed on the main.
Total deals worth $419.1m were announced in Asia-Pacific's technology industry big data deal activity during January 2022 compared to last 12 months: GlobalData